Hyphens Pharma bets big on Asean’s medical aesthetics boom

Hyphens Pharma bets big on Asean’s medical aesthetics boom

[SINGAPORE] Catalist-listed Hyphens Pharma wants to ride on the growing medical aesthetics market across South-east Asia, with the aim of becoming the region’s leading consumer healthcare group. The pharmaceutical company is seeing a growing interest in this segment, as regional economic growth drives evolving consumer behaviours. A rising middle class has emerged – demonstrating greater…

Read More